abstract |
The present invention relates to compounds and pharmaceutical compositions comprising such compounds that modulate the activity of 5-lipoxygenase-activated protein (FLAP). Also described herein are methods for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases using these FLAP modulators alone and in combination with other compounds. |